Institutional Market Intelligence. Built for Serious Investors.
Gain an asymmetric edge with Wall Street-grade IPO valuations, quant earnings breakdowns, and an entirely ad-free reading experience.
FinBasis PRO is 100% Free for the First 3 Months!
Founding readers get full institutional DCF models, IPO health scorecards, and ad-free analysis with zero credit card required.
Free Access
Essential tools, breaking news, and daily IPO GMP tracker for everyday market tracking.
- Daily IPO calendar & exchange bidding tracker
- Public market news & regulatory policy coverage
- Full Broker Directory & SEBI charges calculator
- ✕Institutional Pro deep dives & models
- ✕Ad-Free reading experience
Pro Annual
Best Value — Equivalent to just ₹166/month
Equivalent to just ₹166/month. Save ₹1,589 every year!
- Everything in Pro Monthly, plus:
- Save 44% compared to monthly billing
- Priority Research Access & Quarterly Outlooks
- Multi-Timeframe Technical Breakout Workbooks
- Direct Research Inquiry & Analysis Submissions
- Early access to new quantitative screener models
Cancel anytime in 1 click • GST invoice issued • Instant activation
Compare Plan Capabilities
Clear institutional transparency with zero hidden restrictions.
| Feature | Free | FinBasis Pro |
|---|---|---|
| Daily IPO Calendar & Live Bidding Status | Unlimited | Unlimited + Exchange Snapshots |
Institutional Valuation Models (DCF, Peers) | Locked (Teaser) | Full Access |
Institutional Technical Chart Studies & Breakouts | Locked (Teaser) | Multi-Timeframe Levels |
Forensic Balance Sheet & Corporate Health Audit | Summary Only | 10-Point Scorecard |
Reading Experience | Ad-Supported | 100% Ad-Free |
| Option Greeks & Derivatives Screener | Standard | Advanced Volatility Multi-Strike |
| Community & Analyst Recognition | Reader | Golden Pro Badge |
The FinBasis is a financial technology and quantitative market analytics platform. We are NOT a SEBI-registered Investment Adviser or Research Analyst. All research, valuation models, and educational scenarios are published for informational analysis only and must not be construed as investment advice.